Magnetic Drug Targeting - A new approach in locoregional tumortherapy with chemotherapeutic agents. Experimental animal studies;Magnetisches Drug Targeting - Ein neuer ansatz in der lokoregionären tumortherapie mit chemotherapeutika. Tierexperimentelle untersuchungen

HNO

Volumn 53, Issue 7, 2005, Pages 618-622

  Alexiou, C ^a,e   Jurgons, R ^a   Schmid, R ^a   Erhardt, W ^b   Parak, F ^c   Bergemann, C ^d   Iro, H ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d Chemicell GmbH   (Germany)

^e UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Ferrofluids; Intra arterial chemotherapy; Magnetic Drug Targeting; Magnetic nanoparticles; Nanotechnology

Indexed keywords

ANTINEOPLASTIC AGENT; NANOPARTICLE;

ADVANCED CANCER; ARTICLE; CANCER LOCALIZATION; CANCER THERAPY; CELL COMPARTMENTALIZATION; DRUG TARGETING; MAGNETIC FIELD; NANOTECHNOLOGY; NONHUMAN; SQUAMOUS CELL CARCINOMA; TARGET CELL DESTRUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FERROUS COMPOUNDS; INFUSIONS, INTRA-ARTERIAL; MITOXANTRONE; NANOSTRUCTURES; OTORHINOLARYNGOLOGIC NEOPLASMS; RABBITS;

EID: 23844522812     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00106-004-1146-5     Document Type: Article

References (14)

1. Alexiou C, Arnold W, Klein R et al. (2000) Locoregional cancer treatment with magnetic drug targeting. Cancer Res 60: 6641-6648
2. Alexiou C, Arnold W, Hulin P et al. (2001) Magnetic mitoxantrone nanoparticle detection by histology, x-ray and MRI after magnetic drug targeting. J Magnetism Magn Mater 225: 187-193
3. Alexiou C, Schmidt A, Klein R, Hulin P, Bergemann C, Arnold W (2002) Magnetic drug targeting: biodistribution and dependency on magnetic field strength. J Magnetism Magn Mater 252: 363-366
4. Daniilidis J, Constantinidis J, Fountzilas G (2001) Combined radiochemotherapy in locally advanced nasopharyngeal carcinoma. HNO 49: 732-738
5. Eckardt A, Kelber A, Pytlik C (1995) Palliativ intra-arterial (ia) chemotherapy with carboplatin (CBDCA) and 5-FU in unresectable advanced (stage III-IV) head and neck cancer using implantable port systems. Eur J Surg Oncol 21: 486-489
6. Hilger I, Hiergeist R, Hergt R, Winnefeld K, Schubert H, Kaiser WA (2002) Thermal ablation of tumors using magnetic nanoparticles: an in vivo feasibility study. Invest Radiol 37: 580-586
7. Lübbe AS, Bergemann C, Riess H et al. (1996) Clinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res 56: 4686-4693
8. Robbins KT, Vicario D, Seagren S et al. (1994) A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. Am J Surg 168: 419-442
9. Sagowski C, Kehrl W, Hegewisch-Becker S, Wenzel S, Jaehne M, Panse J, Nierhaus A (2000) Tumor oxygenation in combined whole body hyperthermia and polychemotherapy. Studies exemplified by recurrent carcinoma of the mouth cavity. HNO 48: 949-954
10. Scheel J v, Kastenbauer E (1981) Intraarterielle Cisplatin-Therapie beim adenoid-zystischen Karzinom. HNO 29: 308-311
11. Schmoll HJ, Höffken K, Possinger K (1999) Kompendium internistische Onkologie, Bd 2. Springer, Berlin Heidelberg New York Tokio
12. Volling P, Ebeling O (1999) Adverse effects of cytostatic chemotherapy in patients with head and neck carcinomas. Prevention and therapy. HNO 47: 999-1015
13. Werner JA, Kehrl W, Pluzanska A et al. (2002) A phase III placebo-controlled study in advanced head and neck cancer using intratumoural cisplatin/epinephrine gel. Br J Cancer 87: 938-944
14. Wiedemann G, Mella O, Roszinski S, Weiss C, Wagner T (1992) Hypothermia enhances mitoxantrone cytotoxicity on human breast carcinoma and sarcoma xenografts in nude mice. Int J Radiat Oncol Biol Phys 24: 669-673